Submitted on September 22, 2022
Topic Area(s):
Rahul Aggarwal, MD, discusses the phase 3 PRESTO trial, which he presented at the 2022 ESMO Congress.
Read more here.
Submitted on September 22, 2022
Rahul Aggarwal, MD, discusses the phase 3 PRESTO trial, which he presented at the 2022 ESMO Congress.
Read more here.